LIN PATRICK (Chief Business - Strategy Off) purchased 20.8% of their position (1.58K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $4.1K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/1/2026ACC: 0000897069-26-001289
Officer· Chief Business - Strategy Off
Since Oct 2020
+1.58K
Net shares
Net buyer
$4.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.58K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.58K
Price / share
$2.57
Trade value
$4.07K
% of position
20.8%
5/29/2026
7.59K→9.18K
Total
Net shares
+1.58K
Net value
$4.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | P · Purchase | +1.58K | $2.57 | $4.07K | 20.8% | 7.59K | 9.18K |
| Total | +1.58K | $4.07K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74K
Total
1.74K indirect1.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74K | Indirect |
| Total | 1.74K | 1.74K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported